Reduced Rates of Post-Transplant Recurrent Hepatocellular Carcinoma in Non-Alcoholic Steatohepatitis: A Propensity Score Matched Analysis.


Journal

Transplant international : official journal of the European Society for Organ Transplantation
ISSN: 1432-2277
Titre abrégé: Transpl Int
Pays: Switzerland
ID NLM: 8908516

Informations de publication

Date de publication:
2022
Historique:
received: 02 11 2021
accepted: 13 06 2022
entrez: 22 7 2022
pubmed: 23 7 2022
medline: 26 7 2022
Statut: epublish

Résumé

Non-alcoholic steatohepatitis (NASH)-related hepatocellular carcinoma (HCC) has become the second leading cause of HCC-related liver transplantation in the United States. This study investigated post-transplant recurrence and survival for patients transplanted for NASH-related HCC compared to non-NASH HCC etiologies. Retrospective review of the United Network for Organ Sharing (UNOS) Organ Procurement and Transplantation Network (OPTN) database identified 7,461 patients with HCC-1,405 with underlying NASH and 6,086 with non-NASH underlying diseases. After propensity score matching (PSM) to account for patient- and tumor-related confounders 1,175 remained in each group. Primary outcomes assessed were recurrence rate and recurrence-free survival. Recurrent malignancy at 5 years post-transplant was lower in NASH compared to non-NASH patients (5.80 vs. 9.41%,

Identifiants

pubmed: 35865863
doi: 10.3389/ti.2022.10175
pii: 10175
pmc: PMC9294152
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

10175

Informations de copyright

Copyright © 2022 Lamm, Altshuler, Patel, Shaheen, Amante, Civan, Maley, Frank, Ramirez, Glorioso, Shah, Dang and Bodzin.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Liver Transpl. 2009 Dec;15(12):1814-20
pubmed: 19938128
Int J Cancer. 2015 Mar 1;136(5):E359-86
pubmed: 25220842
Hepatology. 2016 Jul;64(1):73-84
pubmed: 26707365
Exp Mol Med. 2020 Dec;52(12):1898-1907
pubmed: 33268834
Liver Transpl. 2017 Aug;23(8):1015-1022
pubmed: 28340509
Liver Transpl. 2013 Dec;19(12):1318-23
pubmed: 24039140
Clin Gastroenterol Hepatol. 2015 Mar;13(3):594-601.e1
pubmed: 25148760
World J Hepatol. 2017 Apr 18;9(11):533-543
pubmed: 28469809
Dig Dis Sci. 2017 Oct;62(10):2915-2922
pubmed: 28744836
Eur J Cancer. 2017 Nov;86:106-114
pubmed: 28985579
Int J Mol Sci. 2020 Sep 15;21(18):
pubmed: 32942580
Am J Manag Care. 2020 Oct;26(10 Suppl):S220-S226
pubmed: 33052639
Ann Hepatol. 2022 Jan;27 Suppl 1:100568
pubmed: 34699987
Ann Hepatol. 2019 Nov - Dec;18(6):855-861
pubmed: 31543468
Hum Pathol. 2002 Nov;33(11):1098-104
pubmed: 12454814
N Engl J Med. 2008 Jul 24;359(4):378-90
pubmed: 18650514
Gastroenterology. 2011 Oct;141(4):1249-53
pubmed: 21726509
Abdom Radiol (NY). 2018 Jan;43(1):13-25
pubmed: 28647765
Clin Gastroenterol Hepatol. 2019 Mar;17(4):748-755.e3
pubmed: 29908364
Clin Liver Dis. 2015 May;19(2):361-79
pubmed: 25921668
Hepatology. 2014 Jun;59(6):2188-95
pubmed: 24375711
Hepatol Res. 2012 Jan;42(1):1-14
pubmed: 21917086
Hepatobiliary Surg Nutr. 2019 Aug;8(4):411-413
pubmed: 31489317
Ann Intern Med. 2017 May 02;166(9):637-648
pubmed: 28319996
World J Hepatol. 2016 Jul 28;8(21):881-90
pubmed: 27478538
J Gastrointest Surg. 2021 May;25(5):1193-1202
pubmed: 32378092
J Korean Med Sci. 2018 Oct 12;33(45):e283
pubmed: 30402048
J Gastrointest Surg. 2017 Dec;21(12):2033-2038
pubmed: 28785936
Arch Surg. 2008 Feb;143(2):182-8; discussion 188
pubmed: 18283144
Diagn Interv Imaging. 2017 Jan;98(1):37-42
pubmed: 27372418
Hepatology. 2018 Jan;67(1):123-133
pubmed: 28802062
J Hepatocell Carcinoma. 2015 Feb 23;2:19-27
pubmed: 27508191
Annu Rev Med. 2016;67:103-17
pubmed: 26473416
Transplantation. 2018 Apr;102(4):640-647
pubmed: 29319620
Medicine (Baltimore). 2018 Aug;97(31):e11518
pubmed: 30075518
Hepatology. 2012 Jun;55(6):1809-19
pubmed: 22183968
BMC Cancer. 2015 Apr 01;15:210
pubmed: 25884354

Auteurs

Ryan Lamm (R)

Department of Surgery, Thomas Jefferson University Hospital, Jefferson University Hospitals, Philadelphia, PA, United States.

Peter J Altshuler (PJ)

Department of Surgery, Thomas Jefferson University Hospital, Jefferson University Hospitals, Philadelphia, PA, United States.

Keyur Patel (K)

Department of Surgery, Thomas Jefferson University Hospital, Jefferson University Hospitals, Philadelphia, PA, United States.

Osama Shaheen (O)

Department of Surgery, Thomas Jefferson University Hospital, Jefferson University Hospitals, Philadelphia, PA, United States.

Angel Paulo Amante (AP)

Department of Surgery, Thomas Jefferson University Hospital, Jefferson University Hospitals, Philadelphia, PA, United States.

Jesse Civan (J)

Department of Gastroenterology, Thomas Jefferson University Hospital, Jefferson University Hospitals, Philadelphia, PA, United States.

Warren Maley (W)

Department of Surgery, Thomas Jefferson University Hospital, Jefferson University Hospitals, Philadelphia, PA, United States.

Adam Frank (A)

Department of Surgery, Thomas Jefferson University Hospital, Jefferson University Hospitals, Philadelphia, PA, United States.

Carlo Ramirez (C)

Department of Surgery, Thomas Jefferson University Hospital, Jefferson University Hospitals, Philadelphia, PA, United States.

Jaime Glorioso (J)

Department of Surgery, Thomas Jefferson University Hospital, Jefferson University Hospitals, Philadelphia, PA, United States.

Ashesh Shah (A)

Department of Surgery, Thomas Jefferson University Hospital, Jefferson University Hospitals, Philadelphia, PA, United States.

Hien Dang (H)

Department of Surgery, Thomas Jefferson University Hospital, Jefferson University Hospitals, Philadelphia, PA, United States.

Adam S Bodzin (AS)

Department of Surgery, Thomas Jefferson University Hospital, Jefferson University Hospitals, Philadelphia, PA, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH